Schizophrenia Program

Physician Photo

Anne Eden Evins, MD, MPH

Director, Center for Addiction Medicine

  • Phone: 617-643-4679
Department of Psychiatry
Clinical Interests
Nicotine addiction
Smoking cessation
Bipolar disorder
Boston: Massachusetts General Hospital
Medical Education
M.P.H., Harvard School of Public Health
MD, Medical University of South Carolina
Residency, Beth Israel Deaconess Medical Center
Residency, Brigham and Women's Hospital
Residency, Massachusetts Mental Health Center
Board Certifications
Psychiatry, American Board of Psychiatry and Neurology
Patient Age Group
Accepting New Patients
Accepting New Patients


Dr. Evins completed her residency in adult psychiatry at the Massachusetts Mental Health Center and Longwood Psychiatry Residency Training Program, where she was Chief Resident. She conducted a fellowship in molecular biology at the Mailman Research Center of McLean Hospital and a second fellowship in clinical research at the Massachusetts GeneralHospital.

Dr. Evins became the Director of the MGH Center for Addiction Medicine and completed a Masters in Public Health with a concentration in Clinical Effectiveness at the Harvard School of Public Health in 2005. She has been an active member of the MGH Schizophrenia and Depression Clinical and Research Program since 1995.

Dr. Evins' research interests include pharmacotherapy for nicotine dependence, negative symptoms of schizophrenia, co-occurring psychiatric and substance use disorders and cognitive dysfunction in schizophrenia. Additionally, she is studying the effects of various medications on reward responsiveness and other potential biomarkers of vulnerability to addiction and of treatment response. She has authored articles, book chapters, and reviews on related topics. Her articles are published in scientific journals, such as American Journal of Psychiatry, Neuropsychopharmacology, Biological Psychiatry, Journal of Clinical Psychopharmacology, and Journal of Neural Transmission.

Dr. Evins has twice received the National Alliance for Research on Schizophrenia and Affective Disorders Young Investigator Award, and has been awarded the New Clinical Drug Evaluation Unit Award for Young Investigators sponsored by the National Institute of Mental Health, the Mass. Dept. of Public Health Young Investigator Award and two career development awards from NIDA.

She is currently supported by six major grants from the National Institutes of Drug Abuse for her work testing novel therapies for nicotine dependence in the general population and in those with co-occuring psychiatric disorders.

Evins named first incumbent of the William Cox Family Professorship

Anne Eden Evins, MD, MPH, director of the MGH Center for Addiction Medicine, recently was recognized for her exceptional work in this area as the first incumbent of the William Cox Family Professorship in Psychiatry in the Field of Addiction Medicine Harvard Medical School.

Longer-term varenicline treatment improves tobacco abstinence for people with serious mental illness

Extended treatment with the smoking cessation drug varenicline significantly improved the ability of individuals with serious mental illness to maintain abstinence from tobacco after a standard 12-week course of treatment.

Center for Addiction Medicine
60 Staniford Street
Boston, MA 02114

Phone: 617-643-4679
Fax: 617-643-1998